Monsanto Still In Talks With Bayer After Rejecting $62B Bid
Monsanto revealed Wednesday that it is still in discussions with German chemicals and drug company Bayer AG and weighing its "alternative strategic options," an update that comes roughly a month after...To view the full article, register now.
Already a subscriber? Click here to view full article